Related Experiment Video
Updated: Jun 28, 2026
07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Behavioral analyses of GHB: receptor mechanisms
Lawrence P Carter1, Wouter Koek, Charles P France
1Clinical Research and Development, Jazz Pharmaceuticals Inc., USA.
Pharmacology & Therapeutics
|November 18, 2008
Summary
Gamma-hydroxybutyrate (GHB) primarily acts via GABAB receptors, but other mechanisms also contribute to its diverse effects. Understanding these complex actions is key for developing safer GHB-based medications.
Area of Science:
- Neuroscience
- Pharmacology
- Behavioral Science
Background:
- Gamma-hydroxybutyrate (GHB) has therapeutic and recreational uses, but its precise mechanism of action remains unclear.
- Behavioral effects of GHB are complex and not fully elucidated, necessitating further investigation into its pharmacological underpinnings.
Purpose of the Study:
- To review how behavioral procedures, particularly drug discrimination, have elucidated GHB's mechanism of action.
- To qualitatively and quantitatively analyze the components of GHB's complex mechanism of action using various drug discrimination procedures.
Main Methods:
- Utilizing drug discrimination procedures to study the behavioral pharmacology of GHB.
- Comparing the mechanisms of GHB with the GABAB receptor agonist baclofen.
Main Results:
- Evidence suggests GHB's behavioral effects are predominantly mediated by GABAB receptors.
- Mechanisms of GHB and baclofen are not identical, with potential roles for GHB receptors and GABAA/GABAB receptor subtypes.
- Findings align with distinct behavioral profiles, abuse liabilities, and therapeutic uses of GHB and baclofen.
Conclusions:
- GHB's effects involve GABAB receptors but also other contributing mechanisms.
- Differences between GHB and baclofen highlight the complexity of GHB's action.
- Further understanding of GHB's pharmacology can inform the development of improved medications with reduced adverse effects.
More Related Videos
Related Concept Videos
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...